(IN BRIEF) Fresenius Medical Care has received FDA 510(k) clearance for its updated 5008X CAREsystem with additional features, enabling the introduction of high-volume hemodiafiltration therapy across the U.S. This new therapy, proven to reduce mortality rates by 23% in patients, … Read the full press release →
Posted in Business, Environment, Financial, Germany, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Science, Security & Safety, Technology
Tagged 5008X CAREsystem, CDX™, Clinical Data Exchange, CONVINCE study, FDA 510(k) clearance, Fresenius Kidney Care, Fresenius Medical Care, FX CorAL dialyzer, hemodialysis, high-volume hemodiafiltration, INNOVATION, kidney care, kidney disease treatment, mortality reduction, partnership, patient care, renal disease, U.S. rollout